News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

ICON Appoints Dr. Ira Spector As Executive Vice President, Analytics And Consulting

9/3/2014 10:11:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Dublin, Ireland, 3rd September, 2014 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Ira Spector as Executive Vice President, Analytics and Consulting. In this role, Dr. Spector will lead ICON’s global consulting and drug development services and will also be responsible for ICON’s business process improvement and analytics capabilities.

Dr. Spector is an expert in clinical development and brings to ICON over 25 years of experience in managing global drug and medical device development programmes. He joins ICON from Allergan Pharmaceuticals, where he was Senior Vice President of Global Development Operations, responsible for staff in 11 global research centres which contributed to approvals in over 51 countries. Prior to Allergan, Dr. Spector spent 17 years at Wyeth Research, most recently as Vice President, Global Development Operations and Vice-Chief of Development. In this role he was responsible for global clinical trial management in Phases 1-3 for oncology and Phases 2-4 for all other therapeutic areas. Dr. Spector was also Vice President and Partner, US Technology Practice, at PA Consulting Group, a leading business technology consulting firm. Dr. Spector received his PhD. in Health Sciences from the University of Medicine and Dentistry of New Jersey, an MBA from Drexel University in Philadelphia, and dual Bachelor of Science degrees in Physics and Electrical Engineering from Washington University, Saint Louis, MO.

Commenting on the appointment, Dr. Steve Cutler, Chief Operating Officer at ICON, said: “I would like to welcome Dr. Spector to the ICON team. His extensive experience in managing some of the world’s largest trials in areas such as oncology, vaccines and CNS, coupled with his expertise in using technology to drive innovation and process improvement, will enable us to provide further strategic input to our customers’ drug and device programmes.”

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 11,000 employees, operating from 83 locations in 38 countries.

Further information is available at

ICON Media Contact
Rebecca Power
Weber Shandwick
Tel: +44 (0) 207 067 0866

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus